Fluoro-2-deoxy-d-glucose PET radiomic analysis predicts outcome in patients with soft tissue sarcoma. Noh A, Thompson SR, Lehane C, Parasyn A, et al. Nucl Med Commun 2025 Nov 28. doi: 10.1097/MNM.0000000000002074.

Read + Share

Amedeo Smart

Independent Medical Education

Noh A, Thompson SR, Lehane C, Parasyn A, et al. Fluoro-2-deoxy-d-glucose PET radiomic analysis predicts outcome in patients with soft tissue sarcoma. Nucl Med Commun 2025 Nov 28. doi: 10.1097/MNM.0000000000002074.
PMID: 41311337